Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 600

1.

Individual pharmacokinetic variation leads to underdosing of ciprofloxacin in some cystic fibrosis patients.

Schultz AN, Høiby N, Nielsen XC, Pressler T, Dalhoff K, Duno M, Buchard A, Johansen HK, Wang H, Dalbøge CS.

Pediatr Pulmonol. 2017 Mar;52(3):319-323. doi: 10.1002/ppul.23638.

PMID:
28221736
2.

Sinus surgery can improve quality of life, lung infections, and lung function in patients with primary ciliary dyskinesia.

Alanin MC, Aanaes K, Høiby N, Pressler T, Skov M, Nielsen KG, Johansen HK, von Buchwald C.

Int Forum Allergy Rhinol. 2016 Nov 23. doi: 10.1002/alr.21873. [Epub ahead of print]

PMID:
27879058
3.

Phenotypic shift in Pseudomonas aeruginosa populations from cystic fibrosis lungs after 2-week antipseudomonal treatment.

Fernández-Barat L, Ciofu O, Kragh KN, Pressler T, Johansen U, Motos A, Torres A, Hoiby N.

J Cyst Fibros. 2016 Sep 16. pii: S1569-1993(16)30601-4. doi: 10.1016/j.jcf.2016.08.005. [Epub ahead of print]

PMID:
27651273
4.

Evaluation of a bovine antibody test for diagnosing Mycobacterium avium complex in patients with cystic fibrosis.

Qvist T, Pressler T, Katzenstein TL, Høiby N, Collins MT.

Pediatr Pulmonol. 2017 Jan;52(1):34-40. doi: 10.1002/ppul.23608.

PMID:
27648735
5.

The dlt genes play a role in antimicrobial tolerance of Streptococcus mutans biofilms.

Nilsson M, Rybtke M, Givskov M, Høiby N, Twetman S, Tolker-Nielsen T.

Int J Antimicrob Agents. 2016 Sep;48(3):298-304. doi: 10.1016/j.ijantimicag.2016.06.019.

PMID:
27502751
6.

Bacterial evolution in PCD and CF patients follows the same mutational steps.

Sommer LM, Alanin MC, Marvig RL, Nielsen KG, Høiby N, von Buchwald C, Molin S, Johansen HK.

Sci Rep. 2016 Jun 28;6:28732. doi: 10.1038/srep28732.

7.

Sinus surgery postpones chronic Gram-negative lung infection: cohort study of 106 patients with cystic fibrosis.

Alanin MC, Aanaes K, Høiby N, Pressler T, Skov M, Nielsen KG, Taylor-Robinson D, Waldmann E, Krogh Johansen H, von Buchwald C.

Rhinology. 2016 Sep;54(3):206-13. doi: 10.4193/Rhin15.347.

PMID:
27116399
8.

Diffusion Retardation by Binding of Tobramycin in an Alginate Biofilm Model.

Cao B, Christophersen L, Kolpen M, Jensen PØ, Sneppen K, Høiby N, Moser C, Sams T.

PLoS One. 2016 Apr 21;11(4):e0153616. doi: 10.1371/journal.pone.0153616.

9.

S100A8/A9 is an important host defence mediator in neuropathic foot ulcers in patients with type 2 diabetes mellitus.

Trøstrup H, Holstein P, Christophersen L, Jørgensen B, Karlsmark T, Høiby N, Moser C, Ågren MS.

Arch Dermatol Res. 2016 Jul;308(5):347-55. doi: 10.1007/s00403-016-1646-7.

PMID:
27084691
10.

[Augmented renal clearance of antibiotics may lead to inadequate dosings for patients with sepsis].

Moser C, Hartvig T, Schierbeck J, Høiby N.

Ugeskr Laeger. 2016 Mar 14;178(11):V05150426. Danish.

PMID:
27032308
11.

Activation of pulmonary and lymph node dendritic cells during chronic Pseudomonas aeruginosa lung infection in mice.

Damlund DS, Christophersen L, Jensen PØ, Alhede M, Høiby N, Moser C.

APMIS. 2016 Jun;124(6):500-7. doi: 10.1111/apm.12530.

PMID:
27009697
12.

The phenotypic evolution of Pseudomonas aeruginosa populations changes in the presence of subinhibitory concentrations of ciprofloxacin.

Wassermann T, Meinike Jørgensen K, Ivanyshyn K, Bjarnsholt T, Khademi SM, Jelsbak L, Høiby N, Ciofu O.

Microbiology. 2016 May;162(5):865-75. doi: 10.1099/mic.0.000273.

PMID:
26953154
13.

Genome Sequence of Pseudomonas aeruginosa Strain DK1-NH57388A, a Stable Mucoid Cystic Fibrosis Isolate.

Norman A, Ciofu O, Amador CI, Høiby N, Jelsbak L.

Genome Announc. 2016 Feb 25;4(1). pii: e00008-16. doi: 10.1128/genomeA.00008-16.

14.

Anti-Pseudomonas aeruginosa IgY antibodies promote bacterial opsonization and augment the phagocytic activity of polymorphonuclear neutrophils.

Thomsen K, Christophersen L, Jensen PØ, Bjarnsholt T, Moser C, Høiby N.

Hum Vaccin Immunother. 2016 Jul 2;12(7):1690-9. doi: 10.1080/21645515.2016.1145848.

15.

OligoG CF-5/20 Disruption of Mucoid Pseudomonas aeruginosa Biofilm in a Murine Lung Infection Model.

Hengzhuang W, Song Z, Ciofu O, Onsøyen E, Rye PD, Høiby N.

Antimicrob Agents Chemother. 2016 Apr 22;60(5):2620-6. doi: 10.1128/AAC.01721-15.

16.

The phagocytic fitness of leucopatches may impact the healing of chronic wounds.

Thomsen K, Trøstrup H, Christophersen L, Lundquist R, Høiby N, Moser C.

Clin Exp Immunol. 2016 Jun;184(3):368-77. doi: 10.1111/cei.12773.

PMID:
26830371
17.

Reinforcement of the bactericidal effect of ciprofloxacin on Pseudomonas aeruginosa biofilm by hyperbaric oxygen treatment.

Kolpen M, Mousavi N, Sams T, Bjarnsholt T, Ciofu O, Moser C, Kühl M, Høiby N, Jensen PØ.

Int J Antimicrob Agents. 2016 Feb;47(2):163-7. doi: 10.1016/j.ijantimicag.2015.12.005.

PMID:
26774522
18.

New technology markedly improves hand-hygiene performance among healthcare workers after restroom visits.

Møller-Sørensen H, Korshin A, Mogensen T, Høiby N.

J Hosp Infect. 2016 Apr;92(4):337-9. doi: 10.1016/j.jhin.2015.09.012.

PMID:
26597634
19.

Chronic pulmonary disease with Mycobacterium abscessus complex is a biofilm infection.

Qvist T, Eickhardt S, Kragh KN, Andersen CB, Iversen M, Høiby N, Bjarnsholt T.

Eur Respir J. 2015 Dec;46(6):1823-6. doi: 10.1183/13993003.01102-2015. No abstract available.

PMID:
26493807
20.

Comparing the harmful effects of nontuberculous mycobacteria and Gram negative bacteria on lung function in patients with cystic fibrosis.

Qvist T, Taylor-Robinson D, Waldmann E, Olesen HV, Hansen CR, Mathiesen IH, Høiby N, Katzenstein TL, Smyth RL, Diggle PJ, Pressler T.

J Cyst Fibros. 2016 May;15(3):380-5. doi: 10.1016/j.jcf.2015.09.007.

Items per page

Supplemental Content

Support Center